The transfusion act and hemovigilance in the Emergency Care Unit of Icoaraci, Belém, Pará

• Autor(a) principal: Gonçalves, Adriellen Saraí de Lima
• Data de Publicação: 2024
• Outros Autores: Foicinha, Joelma da Conceição, Correa, Ronaldo Lucas do Nascimento, Costa, Bruno Wesley Bezerra, Basilio, Márcia Maria Ribeiro, Vieira, Haila Kelli dos Santos, Passos, Márcia Maria Barros dos, Soler, Orenzio
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Research, Society and Development
• Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/45082
• topic: Transfusión de sangre; Hemovigilancia; Cuidado farmacéutico; Servicio farmacéutico; Farmacéutico.; Blood transfusion; Hemovigilance; Pharmaceutical care; Pharmaceutical service; Pharmaceutical.; Transfusão de sangue; Hemovigilância; Assistência farmacêutica; Serviço farmacêutico; Farmacêutico.

Introduction: Blood has essential components for life. Hemovigilance, based on hemotherapy, guarantees the safety of the donor and recipient. Objective: To investigate the transfusion act and the hemovigilance service in the Emergency Care Unit of Icoaraci, Belém, Pará. Methodology: This is an exploratory, qualitative and quantitative study, of the action research type, using convenience sampling , being retrospective for the period from September to December 2022 and prospective for the period from January to February 2023, with a situational diagnosis of the service carried out and the proposition of a model of action for the pharmaceutical professional in the process. Results: It is recorded that December 2022 presented the highest number of blood transfusions, with February 2023 presenting the highest number of post-transfusion reactions (10 cases). Of the transfused patients, there was a prevalence of female patients (55%), with an average age of 42 years. Among the clinical manifestations, the hypertensive peak stood out. The most used blood component was packed red blood cells. Non-conformities were also observed in relation to the technical regulations for hemotherapeutic procedures. Finally, Continuing Education was used to guide the correct performance of the transfusion act. Conclusion: It is recommended to reflect on the importance of the pharmacist's role in hemotherapy; as well as their inclusion in the multidisciplinary team responsible for hemotherapy.